Combination with Methotrexate in a dose> 15 mg per week is contraindicated.
Combinations of drugs that are used with caution
Methotrexate in a dose of less than 15 mg / week: With simultaneous use of drugs, the hematological toxicity of methotrexate is increased because NSAIDs generally decrease the renal clearance of methotrexate, and salicylates in particular are displacing it from the bond with plasma proteins.
Anticoagulants (coumarin, heparin): with the simultaneous administration of ASA and indirect anticoagulants increases the risk of bleeding due to the suppression of platelet function, damage to the mucous membrane of the stomach and duodenum and the displacement of oral anticoagulants from their association with plasma proteins.
Other NSAIDs with salicylates in a high dose (> 3 g / day): while the use of drugs because of synergies increased risk of ulceration of the mucous membrane of the gastrointestinal tract and bleeding.
Urikozuric drugs (benzbromarone, probenecid): the therapeutic effect of uricosuric drugs decreases due to competitive tubular elimination of uric acid.
Digoxin: with simultaneous use of drugs increases the concentration digoxin in the plasma by reducing its excretion.
Antidiabetic drugs (insulin, sulfonylurea): is increasing hypoglycemic effect due to the fact that ASA in high dose has hypoglycemic properties and displaces sulfonylurea from the connection with plasma proteins.
Thrombolytics / antiplatelet drugs of other classes (ticlopidine): increased risk of bleeding.
Diuretics in combination with ASA in a dose of 3 g / day or more: the glomerular filtration decreases, due to a decrease in the synthesis of prostaglandins in the kidneys.
Systemic glucocorticosteroids (GCS) excluding hydrocortisone (used to treat Addison's disease): with simultaneous use of drugs the concentration of salicylates in the blood decreases, as the GCS enhances the elimination of salicylates
Angiotensin-converting enzyme (ACE) inhibitors: while simultaneous use of ACE inhibitors and ASA at a dose of 3 g / day or more, a decrease in the hypotensive effect of ACE inhibitors is noted, due to a decrease in glomerular filtration.
Valproic Acid: ASA disrupts the association of valproic acid with plasma proteins, resulting in increased toxicity.
Alcohol: when combined with ASA, the damaging effect on the mucous membrane of the gastrointestinal tract increases and the bleeding time is prolonged.